PCT V

product on market Capsule Blackstone Labs Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 40% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains ingredients like Tribulus terrestris and Saw Palmetto, which have limited evidence for supporting hormonal balance. NAC provides antioxidant support, while Androst 3,5-Dien-7,17-Dione and Laxogenine are used for anabolic support, though clinical data on their efficacy is sparse. Overall, the evidence coverage for these specific combined ingredients is very low.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for PCT V
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
40%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Tribulus terrestris std. extract
250 mg
Market median: 320.0mg (426 products) 26 studies (A:0, B:5)
NAC
125 mg
Market median: 600.0mg (7 products) 39 studies (A:2, B:13)
Androst 3,5-Dien-7,17-Dione
37.5 mg
Alpha Hydroxy Laxogenine
25 mg

Other Ingredients

Gelatin Magnesium Stearate Rice Flour
Claims

Label Claims — Verification

Unverified Structure/Function
Info

Product Information

Formulation Notes

Post cycle therapy

Additional Information

Uphold, mend, rise

Metadata

Product Details

DSLD Entry Date2019-12-22
Product TypeOther Combinations
FormCapsule
DSLD ID211494
Data Updated2026-04-11
Research

Research Evidence

35
Research Sources
52
Avg Quality
15
Meta Analysis
11
Systematic Review
7
Rct
1
Narrative Review
1
Openfda Safety
B Serenoa repens for benign prostatic hyperplasia
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
B Serenoa repens for benign prostatic hyperplasia
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
B Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis
Meta Analysis Investigative and clinical urology 2021 PubMed DOI
B Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials
Systematic Review European urology focus 2021 PubMed DOI
B Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene
Systematic Review European review for medical and pharmacological sciences 2019 PubMed DOI
B Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
Meta Analysis American journal of men's health 2020 PubMed DOI
B Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review
Systematic Review BJU international 2012 PubMed DOI
B Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis
Systematic Review Frontiers in nutrition 2025 PubMed DOI
C Benign prostate hyperplasia and nutrition
Systematic Review Clinical nutrition ESPEN 2019 PubMed DOI
C American palm ethnomedicine: a meta-analysis
Meta Analysis Journal of ethnobiology and ethnomedicine 2009 PubMed DOI
View all evidence for Saw Palmetto →
Compare

Similar Products

View all Saw Palmetto products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.